Table 5 Serum lipid profiles of the Kochujang and placebo groups at the 0-wk and at 12-wk of the study

Total cholesterol(mg/dL)

193.4±5.1

189.8±5.9

-3.6±3.9

196.4±6.3

197.9±5.1

1.5±4.2

0.378

0.047

0.740

0.367

Triglycerides(mg/dL)

112.5±9.1

94.6±5.8 ^†

-17.9±8.5

125.6±12.7

139.1±13.8

13.5±12.9

0.049

0.412

0.026

0.042

HDL (mg/dL)

52.3±1.9

51.2±1.9

-1.07±1.5

52.3±2.2

50.9±1.8

-1.32±1.7

0.912

0.100

0.923

0.670

LDL (mg/dL))

124.9±4.7

122.3±5.2

-0.25±0.14

125.9±6.1

123.6±5.3

-0.15±0.14

0.630

0.188

0.874

0.960

Free fatty acid (μEq/L)

631.8±43.2

604.7±37.4

-27.1±53.9

542.2±34.7

631.9±43.0

89.8±44.0

0.098

0.658

0.669

0.170

ApoA1 (g/dL)

1.44±0.03

1.26±0.03 ^†

-0.18±0.03

1.45±0.04

1.31±0.03 ^†

-0.14±0.03

0.284

0.002

0.729

0.216

ApoB(g/dL)

0.87±0.03

0.70±0.03 ^†

-0.17±0.02

0.88±0.04

0.76±0.04 ^†

-0.12±0.02

0.049

0.001

0.540

0.025

Atherosclerosis Indices

TC/HDL

3.8±0.1

3.4±0.2

-0.42±0.2

3.9±0.2

3.8±0.2

-0.10±0.2

0.303

0.935

0.460

0.357

LDL/HDL

2.4±0.1

2.2±0.1

-0.25±0.1

2.5±0.2

2.3±0.2

-0.15±0.1

0.630

0.976

0.671

0.752

(TC-HDL)/HDL

2.8±0.1

2.5±0.2

-0.32±0.2

2.9±0.2

2.8±0.2

-0.04±0.03

0.253

0.975

0.454

0.297

ApoB/ApoA1

0.61±0.02

0.56±0.03 ^†

-0.05±0.01

0.61±0.03

0.60±0.03

-0.01±0.02

0.296

0.075

0.240

0.593